Integrated Drug Discovery Pipeline for Next Generation Aptamers
Flexmers are next generation aptamers and provide a novel alternative to drug compounds. To enable a very quick and efficient process for flexmer development, ATDBio, Biaffin and FlexMers BV will combine their expertise to create an integrated drug discovery pipeline for flexmers.
2 081 500.00€
Biology / Biotechnology